IP Library Granted Patent US 12,220,664
Granted Patent B2
US 12,220,664 · App. 18/456,320 · Granted Feb 11, 2025

Perfusion filtration system

Inventors: Attila Herczeg (Southborough, MA); Julie-Anne Burdick (Hudson, MA)
Assignee: WaterSep Bioseparations LLC
B01D63/043B01D63/0241B01D65/00C12M23/26C12M29/10C12M41/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,220,664
App. No.
18/456,320
Granted
Feb 11, 2025
Kind
B2
Abstract

Disclosed herein is a perfusion filtration module or bioreactor for filtering a fluid, wherein the filtration module or bioreactor has a plurality of hollow fiber filter membranes that are splayed to reduce fouling of the filtration array.

Claims (34)

1. A perfusion filtration module for filtering a feed fluid, comprising:

a. a fiber array comprising a plurality of hollow fiber filter membranes, each having a first end and a second end, wherein the first ends of the hollow fiber filter membranes are potted, thus forming a first potted end, to enable filtrate flow from the hollow fiber filter membranes, and wherein the second ends of the hollow fiber filter membranes are either:

i. potted, thus forming a second potted end, to enable fluid flow from the hollow fiber filter membranes; or alternatively

ii. mounted, thus forming a mounted end, so that the hollow fiber filter membranes are sealed to prevent filtrate flow;

b. a constraint that allows the hollow fiber filter membranes to be held in a splayed configuration, wherein:

i. the first potted end and the second potted end, or alternatively,

the first potted end and the mounted end, comprise first and second surfaces, respectively, from which the fiber filter membranes emerge, and

ii. a housing, and the first potted ends and the second potted ends, or the mounted ends, of the plurality of hollow fiber filter membranes are fixed relative to the housing;

wherein the splayed configuration is a configuration in which the hollow fiber filter membranes spread out from one another as they extend away from the first potted end and the second potted end, or the mounted end, to increase an interstitial distance between adjacent ones of the plurality of hollow fiber filter membranes across a width of the perfusion filtration module between the first potted end and the second potted end, or the mounted end, and

wherein the splayed configuration has a degree of splay and the degree of splay is greater than 1, wherein the degree of splay is the relative amount of splay expressed as a ratio of the maximum lateral dimension of the splayed fiber array to the lateral dimension of the fiber array when stretched in its maximum lineal dimension.

2. The perfusion filtration module of claim 1 , further comprising a protective enclosure to prevent the hollow fiber filter membranes in splayed configuration from being damaged during stirring or other motion.

3. The perfusion filtration module of claim 2 , wherein the protective enclosure is metal or plastic, comprising woven or non-woven fabrics, plastics, or metals.

4. The perfusion filtration module of claim 1 , wherein the first and second surfaces are flat.

5. The perfusion filtration module of claim 1 , wherein the first and second surfaces are planar.

6. The perfusion filtration module of claim 5 , wherein when in use, the first ends of the hollow fiber membranes and the second ends of the hollow fiber membranes are mounted or potted so as to emerge from the first and second surfaces, respectively, at angles approximately normal to the first and second surfaces.

7. The perfusion filtration module of claim 5 , wherein the degree of splay is between 1.1 and 15.

8. The perfusion filtration module of claim 5 , wherein the degree of splay is between 1.2 and 12.

9. The perfusion filtration module of claim 5 , the degree of splay is between 1.5 and 10.

10. The perfusion filtration module of claim 5 , the degree of splay is between 1.5 and 8.

11. The perfusion filtration module of claim 5 , the degree of splay is between 2 and 7.

12. The perfusion filtration module of claim 5 , wherein the degree of splay bends the fiber filter without buckling.

13. The perfusion filtration module of claim 1 , further comprising a housing, said housing comprising at least 1 inlet port for admitting feed fluid so as to come into contact with the upstream side of the fiber filter membranes, a manifold, in fluidic contact with the inside of the fiber filter membranes, such that it receives or feeds fluid from or into the inside of the fiber filter membranes, and at least one exit port in fluidic contact with the manifold.

14. The perfusion filtration module of claim 1 , wherein the perfusion filtration module comprises a rod holding the potted first ends and the second potted ends, or the mounted ends, such the hollow fiber filters may be in the splayed configuration.

15. The perfusion filtration module of claim 1 , further comprising a pressure control valve to regulate vacuum, such that the shear rate is maintained below 2300 sec −1 .

16. A membrane bioreactor comprising a perfusion filtration module for filtering a feed fluid, said perfusion filtration module comprising:

a. a fiber array comprising a plurality of hollow fiber filter membranes, each having a first end and a second end, wherein the first ends of the hollow fiber filter membranes are potted, thus forming a first potted end, to enable filtrate flow from the hollow fiber filter membranes, and wherein the second ends of the hollow fiber filter membranes are either:

i. potted, thus forming a second potted end, to enable fluid flow from the hollow fiber filter membranes; or alternatively

ii. mounted, thus forming a mounted end, so that the hollow fiber filter membranes are sealed to prevent filtrate flow;

b. a constraint that allows the hollow fiber filter membranes to be held in a splayed configuration, wherein:

i. the first potted end and the second potted end, or alternatively

the first potted end and the mounted end, comprise first and second surfaces, respectively, from which the fiber filter membranes emerge, and

c. a housing, and the first potted ends and the second potted ends, or the mounted ends, of the plurality of hollow fiber filter membranes are fixed relative to the housing;

wherein the splayed configuration is a configuration in which the hollow fiber filter membranes spread out from one another as they extend away from the first potted end and the second potted end, or the mounted end, to increase an interstitial distance between adjacent ones of the plurality of hollow fiber filter membranes across a width of the perfusion filtration module between the first potted end and the second potted end, or the mounted end, and

wherein the splayed configuration has a degree of splay and the degree of splay is greater than 1, wherein the degree of splay is the relative amount of splay expressed as a ratio of the maximum lateral dimension of the splayed fiber array to the lateral dimension of the fiber array when stretched in its maximum lineal dimension.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: BURDICK, JULIE-ANNE; HERCZEG, ATTILA
To: WATERSEP BIOSEPARATIONS CORPORATION
Reel/Frame 064711/0021 →
CHANGE OF NAME Recorded Aug 25, 2023
From: WATERSEP BIOSEPARATIONS CORPORATION
To: WATERSEP BIOSEPARATIONS LLC
Reel/Frame 064729/0557 →
Continuity (2)
Continuation 16813656 · Mar 9, 2020
Related Publication 20230405528A1 · Dec 21, 2023
References Cited (22)
US 6544424B1 · Shevitz et al. · 2003 [cited by applicant]
US 20060201876A1 · Jordan · 2006 [cited by applicant]
US 20070163942A1 · Tanaka · 2007 [cited by examiner]
US 20140093952A1 · Serway · 2014 [cited by applicant]
US 20160194589A1 · Liderfelt et al. · 2016 [cited by applicant]
US 20170292103A1 · Cattaneo et al. · 2017 [cited by applicant]
US 20190070564A1 · Love et al. · 2019 [cited by applicant]
US 20190314567A1 · Straube et al. · 2019 [cited by applicant]
KR 100638322B1 · 2006 [cited by applicant]
KR 20130124634A · 2013 [cited by applicant]
WO WO0159061 · 2001 [cited by applicant]
WO WO2018183971 · 2018 [cited by applicant]
Castilho et al., “An integrated process for mammalian cell perfusion cultivation and product purification using a dynamic filter,” [cited by applicant]
Chapman LAC, Shipley RJ, Whiteley JP, Ellis MJ, Byrne HM, et al. (2014) Optimising Cell Aggregate Expansion in a Perfused Hollow Fibre Bioreactor via Mathematical Modelling. PLoS One 9(8): e105813. doi: 10.1371/joumal.p… [cited by applicant]
Conversion of Bioreactors to Continuous Perfusion Using Hollow Fiber Cell Separators Practical Aspects Spectrum Laboratories Retrieved Dec. 31, 2019. [cited by applicant]
Davis et al., “Modeling perfusion at small scale using ambr15TM,” 2015. [cited by applicant]
International Search Report and Written Opinion, mailed May 7, 2021, issued for International Patent Application No. PCT/US2021/020504, 7 pages. [cited by applicant]
Menshutina et al., “Modelling of hollow fiber membrane bioreactor for mammalian cell cultivation using computational hydrodynamics,” [cited by applicant]
Tapia et al., “Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production,” [cited by applicant]
Vermasvuori et al., “Economic comparison of diagnostic antibody production in perfusion stirred tank and in hollow fiber bioreactor processes,” [cited by applicant]
Walther et al., “The effects of alternating tangential flow (ATF) residence time, hydrodynamic stress, and filtration flux on high-density perfusion cell culture,” [cited by applicant]
Wang et al., “Larger pore size hollow fiber membranes as a solution to the product retention issue in filtration-based perfusion bioreactors,” [cited by applicant]